Literature DB >> 217527

The triad of hemochromatosis, hepatoma and erythrocytosis.

B Raphael, A A Cooperberg, P Niloff.   

Abstract

The triad of hemochromatosis, hepatoma and erythrocytosis is a rare combination. Hemochromatosis is often not recognized until the patient presents with the symptoms of hepatocellular carcinoma and erythrocytosis, and the development of erythrocytosis is an important clue to the under-lying hepatoma. The high serum iron concentration and the high saturation of the iron-binding protein, as well as the typical bone marrow hemosiderin pattern, are important aids in the recognition of hemochromatosis. To date, all patients with this triad have been elderly males. The clinical course is usually one of rapid deterioration and death. The seven previously reported cases have been reviewed and the relationship of the erythrocytosis to the increased production of erythropoietin is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 217527     DOI: 10.1002/1097-0142(197902)43:2<690::aid-cncr2820430241>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Diagnosis and management of non-clonal erythrocytosis remains challenging: a single centre clinical experience.

Authors:  Saša Anžej Doma; Eva Drnovšek; Aleša Kristan; Martina Fink; Matjaž Sever; Helena Podgornik; Tanja Belčič Mikič; Nataša Debeljak; Irena Preložnik Zupan
Journal:  Ann Hematol       Date:  2021-05-19       Impact factor: 3.673

2.  Hemochromatosis, Erythrocytosis and the JAK2 p.V617F Mutation.

Authors:  Stephen E Langabeer
Journal:  EJIFCC       Date:  2017-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.